CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData Read more
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in 2023: GlobalData Read more
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData Read more
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData Read more